Yingtai Medical: Plans to apply for A-share issuance and listing on the ChiNext Board of the Shenzhen Stock Exchange.

Yingtai Medical announced that its board of directors has approved the proposed A-share issuance and related matters. The company plans to publicly issue no more than 37.2706 million A-shares, representing no more than 15% of the total share capital after the issuance, with an over-allotment option of no more than 15% of the aforementioned issuance size. Guotai Haitong Securities is the sponsor. The issuance aims to raise RMB 1.8 billion, to be used for projects including a medical device industrial park, expansion, research and development, marketing network construction, and working capital replenishment and debt repayment. Meanwhile, the board also approved the draft articles of association and governance rules applicable after the A-share listing, as well as amendments to the H-share award trust scheme, allowing the trustee to buy and sell H-shares through on-market or off-market transactions. The aforementioned A-share-related matters still require approval from an extraordinary general meeting and regulatory authorities.